Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -60.46% is 95% above its 5-year average of -1276.22%, near the high end of its 5-year range (-10135.37%–96.66%).
64.45% above its 12-month average of -170.08%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -160.05%.
GROSS MARGIN
-60.46%
GROSS MARGIN AVG TTM
-170.08%
GROSS MARGIN AVG 3Y
-106.96%
GROSS MARGIN AVG 5Y
-1276.22%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+64.45%
CURRENT VS 3Y AVG
+43.47%
CURRENT VS 5Y AVG
+95.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.56%
median of 755 covered companies
CURRENT VS SECTOR MEDIAN
-252.83%
vs the sector median at left
Akanda Corp.
Market Cap
$61819.00
Gross Margin
-60.46%
TTM Avg
-170.08%
3Y Avg
-106.96%
5Y Avg
-1276.22%
Market Cap
$71496.00
Gross Margin
-4864.71%
TTM Avg
-2432.36%
3Y Avg
-1195.54%
5Y Avg
-797.02%
Market Cap
$30509.00
Gross Margin
-11.45%
TTM Avg
3.36%
3Y Avg
12.08%
5Y Avg
7.57%
Market Cap
$95000.00
Gross Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109442.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6235.00
Gross Margin
N/A
TTM Avg
26.93%
3Y Avg
28.12%
5Y Avg
27.47%
Market Cap
$381940.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
2.16%
5Y Avg
0.42%
Market Cap
$559702.00
Gross Margin
20.00%
TTM Avg
28.69%
3Y Avg
28.89%
5Y Avg
35.93%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | -60.46% | -170.08% | -106.96% | -1276.22% |
| PRF Technologies Ltd. (PRFX)vs › | $71496.00 | -4864.71% | -2432.36% | -1195.54% | -797.02% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | -11.45% | 3.36% | 12.08% | 7.57% |
| Psyence Biomedical Ltd. (PBM)vs › | $95000.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109442.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| NewGenIvf Group Limited (NIVF)vs › | $6235.00 | N/A | 26.93% | 28.12% | 27.47% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | 2.16% | 0.42% |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | 20.00% | 28.69% | 28.89% | 35.93% |
| CDT Equity Inc. (CDT)vs › | $685948.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Ridgetech, Inc. (RDGT)vs › | $773249.00 | N/A | 3.40% | 12.49% | 15.69% |
Gross Margin
-60.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -160.05% |
| 2025-12-31 | -350.19% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 96.66% |
| 2024-06-30 | -29.19% |
| 2023-12-31 | -108.05% |
| 2023-06-30 | -197.87% |
| 2022-12-31 | -112.09% |
| 2022-06-30 | -10135.37% |
| 2021-12-31 | -2993.59% |
| 2021-06-30 | -48.65% |
| 2020-12-31 | -1.46% |
| 2020-06-30 | 14.37% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
